Blood Pressure Control Crisis in Primary Care: When Seeing Patients Isn’t Enough
What if the real blood pressure crisis isn’t about access to care — but what happens inside the visit?
Nearly half of American adults live with hypertension. Many see their primary care providers regularly. Yet control rates remain dangerously low.
So what’s going wrong?
During this episode of Digital Health Talks, Dr. Andrew M. Davis discussed a groundbreaking AI-driven study revealing a sobering truth hiding in plain sight: nearly 30% of patients with hypertension have dangerously uncontrolled blood pressure despite consistent primary care visits.
This isn’t a care access problem.
It’s a care execution problem.
From Routine Metrics to Real Clinical Intelligence
At the center of this discovery is Dr. Andrew M. Davis, Professor and Associate Vice-Chair for Quality at the University of Chicago Medicine, alongside Amy Wainwright, PharmD, a clinical pharmacist leading remote patient monitoring efforts.
Using cloud-based machine learning across 37,000+ patients and 112 providers, their team uncovered what traditional dashboards failed to show:
Underutilized medication combinations
Missed specialist referrals
Inadequate dose titration
Persistent racial and socioeconomic disparities
Patients cycling through visits without meaningful escalation of care
This wasn’t retrospective reporting.
It was real-time clinical insight actionable at the point of care.
And more importantly: they didn’t stop at identifying the problem.
This Isn’t a Hypothesis — It’s Already Working
What makes this work different is what came next.
Instead of producing another static quality report, Dr. Davis’s team used AI-powered queries to deliver precise, provider-level feedback — identifying not just who was uncontrolled, but why.
From there, targeted interventions followed:
Smart prescribing tools highlighting affordable combination medications
Automated identification of patients needing referrals to cardiology or nephrology
Integration with remote patient monitoring using Bluetooth-enabled BP cuffs
Deployment of population health nurses and clinical pharmacists
Digital navigators ensuring patients could actually use the technology
The result?
Clinicians weren’t overwhelmed — they were empowered.
Why It Matters
The implications extend far beyond hypertension.
✔️ Clinical Impact: Earlier intervention reduces heart failure, stroke, and kidney disease
✔️ Equity Gains: Data exposes and helps close long-standing racial control gaps
✔️ Provider Satisfaction: Clear, timely feedback makes it easier to do the right thing
✔️ System ROI: Fewer ER visits, dialysis starts, and avoidable hospitalizations
✔️ Patient Outcomes: Simpler regimens, fewer pills, better adherence
As Dr. Davis put it plainly:
“If you make it easy to do the right thing, clinicians will do it.”
Beyond Hypertension: A Platform for Prevention
What began as a blood pressure initiative is rapidly becoming something larger.
The same analytics are now being applied to:
Early-stage diabetes
Renal disease progression
Heart failure management
Younger populations at long-term cardiovascular risk
By identifying patients years before complications emerge, this model shifts healthcare from reactive sick care to true prevention-first medicine.
And as health systems increasingly tie quality to financial sustainability, real-time clinical intelligence becomes not just helpful but essential.
A Call to Rethink Primary Care Measurement
For healthcare leaders, innovators, and clinicians, the takeaway is clear:
The problem isn’t that we lack data.
It’s that we’ve been looking at it too late, too broadly, and without context.
The future of primary care won’t be built on static reports or retrospective scorecards.
It will be driven by real-time, clinician-informed analytics that translate insight into action — while there’s still time to change outcomes.
Dr. Andrew Davis and Amy Wainwright’s message on Digital Health Talks wasn’t just informative — it was a playbook for modern chronic disease management.
One that’s data-driven, team-based, equity-aware, and operationally realistic.
Because controlling blood pressure isn’t about seeing patients more often.
It’s about seeing what actually needs to change and acting on it.
If you want to hear directly from the leaders redefining how AI turns EHR data into real clinical impact, don’t miss upcoming conversations and live events from HealthIMPACT Live.
Join the dialogue shaping the next era of care where insight arrives on time, prevention starts early, and technology finally works with clinicians, not against them.
Watch the Talk
Experts
Dr. Andrew M. Davis, MD, MPH,
Dr. Andrew M. Davis, MD, MPH, brings a rare and multidimensional perspective to primary care—one shaped by leadership in medicine, public health, and large-scale healthcare systems. A Professor and Associate Vice-Chair for Quality in the Department of Medicine at the University of Chicago, Dr. Davis is board certified in both internal medicine and public health. His work spans the exam room, the classroom, and population-level care, combining hands-on clinical practice with a deep commitment to improving quality, prevention, and chronic disease management.
What distinguishes Dr. Davis is not only his academic and clinical credentials, but his ability to bridge individual patient care with systemic improvement. As a practicing clinician-educator, he provides direct patient care in both the Primary Care Group and the University of Chicago Student Health Clinic, while mentoring future physicians. Over time, his work revealed a critical tension in healthcare: delivering evidence-based care at the bedside is essential, but lasting impact requires redesigning how care is delivered across entire populations.
Grounded in rigorous training—earning his MD from the University of Chicago Pritzker School of Medicine, completing residency at the University of Iowa, and obtaining a Master of Public Health in occupational and environmental health—Dr. Davis translated insight into action. He has led disease management programs serving more than 400,000 individuals, contributed to national practice guidelines as a section editor for JAMA, and served as a visiting scientist at the CDC. His work also extends to advancing equity in care, including leadership in LGBT health and a nationally commissioned review on cardiovascular health disparities for the Robert Wood Johnson Foundation—demonstrating a career defined not only by expertise, but by measurable impact on how healthcare systems serve diverse communities.
